Clinical Trials Browser

Advanced/Metastatic Solid Tumors × pembrolizumab × 1 year × Clear all

NCT05405595 2026-01-07

ADG126 in Combination With Pembrolizumab in Patients With Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced/Metastatic Solid Tumors